{"id":"W3084251940","doi":"10.1093/jnci/djaa119","title":"Optimizing Survival and the Changing Landscape of Targeted Therapy for Intermediate and Advanced Hepatocellular Carcinoma: A Systematic Review","year":2020,"lang":"en","type":"review","venue":"JNCI Journal of the National Cancer Institute","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Dalhousie University; University of Toronto; University of Calgary; Princess Margaret Cancer Centre; University of British Columbia","funders":"Eli Lilly Canada; Eisai Canada","keywords":"Sorafenib; Regorafenib; Medicine; Lenvatinib; Bevacizumab; Oncology; Ramucirumab; Targeted therapy; Hepatocellular carcinoma; Atezolizumab; Cabozantinib; Internal medicine; Clinical trial; Nivolumab; Cancer; Overall survival; Chemotherapy; Immunotherapy; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004147664,0.0009261778,0.005110508,0.005304528,0.0003222632,0.001702264,0.001112009,0.001098935,0.002844424],"category_scores_gemma":[0.01762466,0.0005218337,0.004982783,0.006922495,0.0004920808,0.001485303,0.0008950027,0.0007755661,0.0001759986],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002089627,"about_ca_system_score_gemma":0.008064367,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005560325,"about_ca_topic_score_gemma":0.01732727,"domain_scores_codex":[0.9972709,0.001119353,0.0009106387,0.0002310301,0.0003735479,0.00009452609],"domain_scores_gemma":[0.987603,0.008965963,0.002329777,0.0001252604,0.0008197004,0.0001563343],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0002427245,0.0000182166,0.001003732,0.9190337,0.01052833,0.00006055538,0.0001396927,0.0002211124,0.0001280341,0.0003060881,0.001981868,0.06633598],"study_design_scores_gemma":[0.0003525507,0.0003228234,0.006364249,0.8609935,0.09843251,0.0003987828,0.0002776859,0.0001985259,0.0001649415,0.0006932453,0.03174726,0.00005393377],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000666472,0.9986215,0.00006886206,0.0002251462,0.00003859524,0.00006314139,0.0001667973,0.000003011253,0.000146474],"genre_scores_gemma":[0.01118035,0.9877935,0.0002942862,0.0003495525,0.00004791173,0.0001424855,0.0001375979,0.000002478079,0.00005176627],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005560325,"threshold_uncertainty_score":0.02193522,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1017775641093948,"score_gpt":0.3331779558771525,"score_spread":0.2314003917677577,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}